Skip to main content
SpringerLink
Log in

Heart Failure in the Fetus with Congenital Heart Disease

  • Chapter
  • First Online:
Heart Failure in Congenital Heart Disease:

Abstract

The cardiovascular system before birth is a unique, dynamic and complex organ system. In the fetus, physiological manifestations of the failing heart differ from that seen in the adult, child or infant for a number of reason. First, biological phenomena prior to birth can vary based on maturational changes that take place during different periods of gestation. Second, the diseases and ailments that afflict the fetal heart are of a different nature than that seen after birth and are unique to the developing human fetus. Finally, complex interactions take place between the developing fetus, its richly vascularized placenta and the supportive maternal circulation, creating a fascinating interplay of physiologies between the maternal mature and fetal immature systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Tongsong T, Wanapirak C, Sirichotiyakul S, Piyamongkol W, Chanprapaph P. Fetal sonographic cardiothoracic ratio at midpregnancy as a predictor of Hb Bart disease. J Ultrasound Med. 1999;18:807–811.

    PubMed  CAS  Google Scholar 

  2. Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. 1990;65:20–23.

    Article  PubMed  CAS  Google Scholar 

  3. Shaw SL. Fetal Cardiomyopathies. In: Drose, ed. Fetal Echocardiography. Philadelphia, PA: Saunders; 1998:263–277.

    Google Scholar 

  4. Chaoui R, Bollmann R, Goldner B, Heling KS, Tennstedt C. Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther. 1994;9:92–104.

    Article  PubMed  CAS  Google Scholar 

  5. Respondek M, Respondek A, Huhta JC, Wilczynski J. 2D echocardiographic assessment of the fetal heart size in the 2nd and 3rd trimester of uncomplicated pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;44:185–188.

    Article  PubMed  CAS  Google Scholar 

  6. Makikallio K, Jouppila P, Rasanen J. Human fetal cardiac function during the first trimester of pregnancy. Heart. 2005;91:334–338.

    Article  PubMed  CAS  Google Scholar 

  7. Barrea C, Alkazaleh F, Ryan G, McCrindle BW, Roberts A, Bigras JL et al. Prenatal cardiovascular manifestations in the twin-to-twin transfusion syndrome recipients and the impact of therapeutic amnioreduction. Am J Obstet Gynecol. 2005;192:892–902.

    Article  PubMed  Google Scholar 

  8. Tsyvian P, Malkin K, Artemieva O, Wladimiroff JW. Assessment of left ventricular filling in normally grown fetuses, growth-restricted fetuses and fetuses of diabetic mothers. Ultrasound Obstet Gynecol. 1998;12:33–38.

    Article  PubMed  CAS  Google Scholar 

  9. Wong SF, Chan FY, Cincotta RB, McIntyre HD, Oats JJ. Cardiac function in fetuses of poorly-controlled pre-gestational diabetic pregnancies-a pilot study. Gynecol Obstet Invest. 2003;56:113–116.

    Article  PubMed  CAS  Google Scholar 

  10. Huhta JC. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol. 2004;25:274–286.

    Article  PubMed  CAS  Google Scholar 

  11. Axt-Fliedner R, Wiegank U, Fetsch C, Friedrich M, Krapp M, Georg T et al. Reference values of fetal ductus venosus, inferior vena cava and hepatic vein blood flow velocities and waveform indices during the second and third trimester of pregnancy. Arch Gynecol Obstet. 2004;270:46–55.

    Article  PubMed  CAS  Google Scholar 

  12. Arbeille P, Body G, Saliba E, Tranquart F, Berson M, Roncin A et al. Fetal cerebral circulation assessment by Doppler ultrasound in normal and pathological pregnancies. Eur J Obstet Gynecol Reprod Biol. 1988;29:261–273.

    Article  PubMed  CAS  Google Scholar 

  13. Mielke G, Benda N. Cardiac output and central distribution of blood flow in the human fetus. Circulation. 2001;103:1662–1668.

    PubMed  CAS  Google Scholar 

  14. De Smedt MC, Visser GH, Meijboom EJ. Fetal cardiac output estimated by Doppler echocardiography during mid- and late gestation. Am J Cardiol. 1987;60:338–342.

    Article  PubMed  CAS  Google Scholar 

  15. Wagner HR. Cardiac disease in congenital infections. Clin Perinatol. 1981;8:481–497.

    PubMed  CAS  Google Scholar 

  16. Remington J, McLeod R, Thuilliez P, Desmonts G. Toxoplasmosis. In: Remington J, Klein J, Wilson C, Baker C, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006:947–1091.

    Chapter  Google Scholar 

  17. Pedra SR, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R et al. Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation. 2002;106:585–591.

    Article  PubMed  Google Scholar 

  18. Pedra SR, Hornberger LK, Leal SM, Taylor GP, Smallhorn JF. Cardiac function assessment in patients with family history of nonhypertrophic cardiomyopathy: a prenatal and postnatal study. Pediatr Cardiol. 2005;26:543–552.

    Article  PubMed  CAS  Google Scholar 

  19. Schmidt KG, Birk E, Silverman NH, Scagnelli SA. Echocardiographic evaluation of dilated cardiomyopathy in the human fetus. Am J Cardiol. 1989;63:599–605.

    Article  PubMed  CAS  Google Scholar 

  20. Yinon Y, Yagel S, Hegesh J, Weisz B, Mazaki-Tovi S, Lipitz S et al. Fetal cardiomyopathy-in utero evaluation and clinical significance. Prenat Diagn. 2007;27:23–28.

    Article  PubMed  Google Scholar 

  21. Burwinkel B, Scott JW, Buhrer C, van Landeghem FK, Cox GF, Wilson CJ et al. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet. 2005;76:1034–1049.

    Article  PubMed  CAS  Google Scholar 

  22. Steenhout P, Elmer C, Clercx A, Blum D, Gnat D, van Erum S et al. Carnitine deficiency with cardiomyopathy presenting as neonatal hydrops: successful response to carnitine therapy. J Inherit Metab Dis. 1990;13:69–75.

    Article  PubMed  CAS  Google Scholar 

  23. Hecher K, Snijders R, Campbell S, Nicolaides K. Fetal venous, intracardiac, and arterial blood flow measurements in intrauterine growth retardation: relationship with fetal blood gases. Am J Obstet Gynecol. 1995;173:10–15.

    Article  PubMed  CAS  Google Scholar 

  24. Kirkinen P, Jouppila P, Eik-Nes S. Umbilical vein blood flow in rhesus-isoimmunization. Br J Obstet Gynaecol. 1983;90:640–643.

    Article  PubMed  CAS  Google Scholar 

  25. Ruma MS, Moise KJ, Jr., Kim E, Murtha AP, Prutsman WJ, Hassan SS et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol. 2007;196:138–136.

    Article  PubMed  CAS  Google Scholar 

  26. Rychik J, Tian Z, Bebbington M, Xu F, McCann M, Mann S, Wilson RD, Johnson MP. The twin-twin transfusion syndrome: spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease. Am J Obstet Gynecol. 2007;197:392.e1–e8.

    Google Scholar 

  27. Albert TJ, Landon MB, Wheller JJ, Samuels P, Cheng RF, Gabbe S. Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 1996;174:1424–1428.

    Article  PubMed  CAS  Google Scholar 

  28. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994;84:515–520.

    PubMed  CAS  Google Scholar 

  29. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1–9.

    PubMed  CAS  Google Scholar 

  30. Meyer-Wittkopf M, Simpson JM, Sharland GK. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol. 1996;8:8–10.

    Article  PubMed  CAS  Google Scholar 

  31. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am. 1996;23:221–241.

    Article  PubMed  CAS  Google Scholar 

  32. Jaeggi ET, Fouron JC, Proulx F. Fetal cardiac performance in uncomplicated and well-controlled maternal type I diabetes. Ultrasound Obstet Gynecol. 2001;17:311–315.

    Article  PubMed  CAS  Google Scholar 

  33. Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv. 1985;40:61–68.

    Article  PubMed  CAS  Google Scholar 

  34. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003;89:913–917.

    Article  PubMed  CAS  Google Scholar 

  35. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998;79:576–581.

    PubMed  CAS  Google Scholar 

  36. Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol. 2003;42:765–770.

    Article  PubMed  CAS  Google Scholar 

  37. Jouannic JM, Delahaye S, Fermont L, Le Bidois J, Villain E, Dumez Y et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat Diagn. 2003;23:152–156.

    Article  PubMed  Google Scholar 

  38. Ebenroth ES, Cordes TM, Darragh RK. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol. 2001;22:483–487.

    Article  PubMed  CAS  Google Scholar 

  39. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 2002;19:158–164.

    Article  PubMed  CAS  Google Scholar 

  40. Kohl T, Tercanli S, Kececioglu D, Holzgreve W. Direct fetal administration of adenosine for the termination of incessant supraventricular tachycardia. Obstet Gynecol. 1995;85:873–874.

    Article  PubMed  CAS  Google Scholar 

  41. Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus. 2002;11:716–721.

    Article  PubMed  CAS  Google Scholar 

  42. Menendez T, Achenbach S, Beinder E, Hofbeck M, Klinghammer L, Singer H et al. Usefulness of magnetocardiography for the investigation of fetal arrhythmias. Am J Cardiol. 2001;88:334–336.

    Article  PubMed  CAS  Google Scholar 

  43. Taylor MJ, Smith MJ, Thomas M, Green AR, Cheng F, Oseku-Afful S et al. Non-invasive fetal electrocardiography in singleton and multiple pregnancies. BJOG. 2003;110:668–678.

    Article  PubMed  Google Scholar 

  44. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart. 1996;75:190–194.

    Article  PubMed  CAS  Google Scholar 

  45. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol. 2002;39:130–137.

    Article  PubMed  Google Scholar 

  46. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. 1999;42:2335–2345.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Fetal Heart Program, Cardiac Center at The Children’s Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104, US

    Jack Rychik

Authors
  1. Deepika Thacker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack Rychik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack Rychik .

Editor information

Editors and Affiliations

  1. Children's Hospital of Philadelphia, South 34th Street, Philadelphia, 19151, Pennsylvania, USA

    Robert. E Shaddy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Thacker, D., Rychik, J. (2010). Heart Failure in the Fetus with Congenital Heart Disease. In: Shaddy, R. (eds) Heart Failure in Congenital Heart Disease:. Springer, London. https://doi.org/10.1007/978-1-84996-480-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-480-7_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-479-1

  • Online ISBN: 978-1-84996-480-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation